📌 Key Takeaways
- Topic: Silica Supply Chain: Raw Materials, Production Hubs and Risks
- Keywords: hollow silica
- Published: 2026-11-20 01:18:01
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica for Wafer Polishing: Slurry Types, Particle Size and Performance
- Silica Supplier Vietnam: Market Overview and Sourcing Options
- Silicon Dioxide Supplier: How to Choose the Right Grade and Reliable Partner
- Desai, P. P., Date, A. A. & Patravale, V. B. Overcoming poor oral bioavailability utilizing nanoparticle formulations-opportunities and limitations. Drug Discov. Today Technol. 9, e87-e95 (2012). Post CAS Google Scholar
- Silica Market Trends 2026: Demand Drivers, Technologies and Regional Outlook
- Semiconductor Grade Silica: Purity Standards, Key Specs and Typical Uses
- Bukara, K. et al. Ordered mesoporous silica to enhance the bioavailability of poorly water-soluble drugs: Proof of idea in man. Eur. J. Pharm. Biopharm. 108, 220-225 (2016). Article CAS PubMed Google Scholar
Fumed Silica vs Precipitated Silica: Differences in Production, Properties and Uses
What is silica (SiO₂)?
what is silica
What is the difference between fumed silica and precipitated silica?
foundry silica sand
What drives silica raw material prices?
toothpaste grade silica For metal sulfide NPs/MSNs nanocomposites, the small-sized CdS NPs as a gatekeeper is the first example of MSNs-based therapeutic system for controlled drug delivery, reported in 2003. 51 Other metal sulfides such as copper sulfide (CuS), molybdenum disulfide (MoS 2 ) and bismuth sulfide (Bi 2 S 3 ) exhibit high NIR absorption coefficients in the NIR region owing to their plasmon resonance effect or electron-hole generation and relaxation mechanism, 182, 183, 184, 185, 186 and consequently those metal sulfides NPs can serve as potential photothermal agents. For instance, hollow MSNs functionalized with chitosan were synthesized, and then loaded with CuS nanodots. The CuS nanodots could act as a gatekeeper to seal the surface pores of MSNs, leading to the controllable release of DOX. The as-resulted CuS/MSNs-based therapeutic nanoplatform, with the photothermal conversion efficiency being 36.4%, dramatically extended the survival rate of tumor-bearing mice by the photothermal-enhanced synergistic therapy. 162 Similarly, in another study, the MoS 2 nanosheets with brilliant photothermal conversion capacity were also used as a capping agent to block MSNs to realize the drug release. Experimental results demonstrated that the MoS 2 /MSNs nanocomposite has the capability of pH-dependent and photothermal-triggered DOX release, consequently achieving the targeted tumor killing by the combination of chemotherapy and PTT. 187
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.